Replies to post #3090 on Alexza Pharmaceuticals Inc fka ALXA

[BiotechGuy49]

It's run on insider purchases twice now in the past 2 months. Wonder if it'll stay up this time.

[L2PlayPennies]

I'm not too sure. Looking back on Aug 5th we had a move like this and gave it back over the next few days. I do like the volume and hope it holds.
I follow the $heff board and he has this one his watch list. I'm wondering if he is going to post about it today because of the move.

$heff Friday, September 06, 2013 12:21:04 AM
Re: $heff post# 70435 Post # of 71568

ALXA..$4.64..on watch here as Adasuve should launch in Q3:
t.co/J6DkgIgIyt


In the report, Duncan noted, “Our outreach to ER physicians, psychiatrists, and opinion leaders points to several factors that enhance our conviction on both the near- and longer-term market potential for Adasuve versus our previous projections. Additionally, we believe Adasuve clinical attributes underlying our new perspective bode well for a value-added partnership being signed soon to enable effective launch in 3Q13. We anticipate several metrics for tracking early Adasuve commercialization, including P&T committee decisions, formulary acceptance, initial and new orders, as well as physicians completing the REMs program and progress with the Phase IV study, which may or may not be reported by Alexza.”